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SHORT COMMUNICATION
Insulin and glucose status, tissue and plasma lipids in patients with
tumours of the ovary or endometrium: possible dietary implications
D. Yam', H. Ben-Hur2, A. Fink3, R. Dgani2, A. Shani4, A. Eliraz5, V. Insler2 & E.M. Berry6
'The Weizmann Institute ofScience, 2Department ofObstetrics and Gynecology, 3Chemical Laboratories, 4Institute ofOncology,
SPulmonary Unit, Kaplan Hospital, Rehovot, Israel; 6Department ofHuman Nutrition and Metabolism, Hebrew University,
Hadassah Medical School, Jerusalem, Israel.
Summary The relationship between tumour growth, insulin status, blood lipids and adipose linoleic acid (LA,
reflecting long-term LA intake) was studied in 19 Jewish women suffering from early and advanced stages (ES
and AS) of ovarian and endometrial tumours. Blood insulin in patients with ES tumours was four times higher
than the control value in cancer-free subjects, but fell to normal levels at AS and after ES surgery (PES).
Tumours and abdominal adipose tissue (AAT) had 4-6 and 1.4-1.7 times as much insulin as non-cancerous
control organs. Serum total cholesterol (CHOL) and LDL-cholesterol were high at ES, dropped below normal
at AS, but normalised at PES, while HDL-cholesterol increased after ES surgery. Linoleic acid in sub-
cutaneous adipose tissue (SAT) was high in controls (26.4 + 1.5% of total fatty acids), but lower in cancer
patients (20.5 + 3.7%, P<0.05), while palmitic acid showed the opposite change. The results suggest mobilisa-
tion of glucose, cholesterol and linoleic acid for the supply of energy and structural lipids to rapidly
multiplying tumour cells and possibly for prostaglandin synthesis. They also raise the question of whether the
high linoleic acid intake by the Jewish population in Israel predisposes individuals to tumour develop-
ment.
The involvement of insulin as a growth factor or anabolic
hormone has been reviewed recently (Yam, 1992). Among
dietary factors, evidence obtained in animals as well as in
humans suggests that LA increases the incidence, growth and
metastasis of tumours (Hubbard & Erikson, 1987) and leads
to hyperinsulinaemia and insulin resistance (Lardinois et al.,
1987). Conflicting observations have been reported regarding
blood cholesterol and its possible relationship to cancer
(Fernleib, 1983).
In order to obtain more information on the relationship
between tumour growth, insulin status, blood lipids and
long-term linoleic acid intake, we examined women suffering
from ovarian and endometrial tumours at ES and AS. This
work forms part of an ongoing study in which a larger
number of patients are being examined.
Materials and methods
The study population comprised 19 patients suffering from
ovarian and endometrial cancer at ES undergoing laparo-
tomy for ovarian tumour stage I or surgery for endometrial
cancer stage I, AS patients undergoing laparotomy for
ovarian tumour stage III and IV or surgery for endometrial
cancer stage II and III. Ten subjects undergoing laparotomy
for non-malignant disease served as controls. ES patients
included obese (BMI >30 kg m2) and non-obese women.
Biopsies of ovary or endometrium and subcutaneous and
abdominal adipose tissue were obtained from cancerous and
non-cancerous patients and kept frozen at -20°C.
Fasting venous blood was taken from cancer patients and
12 healthy controls. A second sample was taken from PES
patients 4-6 months after surgery. Serum was separated and
kept at - 20'C.
Serum and tissue insulin concentration were determined by
a double-antibody radioimmunoassay using '25I-labelled
human insulin (Pharmacia Diagnosis AB, Uppsala,
Sweden).
Other analyses of blood and subcutaneous adipose tissue
(SAT) were carried out according to routine procedures.
Results
No cachexia was observed in any of the cancer patients.
Serum insulin levels were greatly elevated in ES patients
compared with the controls: mean ± s.d. were 30.4 ± 7.2 vs
7.5 ± 2.5 liU ml- ', P<0.05, in 11 and 12 individuals respec-
tively. As patients (n = 8) and PES non-obese patients (n = 5)
yielded values similar to the controls. The insulin contents of
tumours and abdominal adipose tissue are shown in Figure
1. Tumours had 4-6 times as much insulin as non-cancerous
organs (P<0.05), but the slight elevation of insulin concen-
tration in AAT of cancer patients did not reach statistical
significance.
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Figure 1 Insulin content of non-cancerous ovary (OV) and OV
and endometrium (EN) ( _ ) in early and advanced stages of
malignancy (ES and AS), and in abdominal adipose tissue ( M ) from the same patients. Columns represent means with s.d. *Statistically significantly different from control value
(P<0.05).
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Figure 2 Concentrations of serum triglycerides (TG), HDL and
LDL-cholesterol, apolipoprotein A and B (Apo A and B), total
cholesterol (CHOL) and glucose (GLUC) in controls and cancer
patients (means with s.d.). Controls ( _ ), n = 12, early stage
(ES) (0), n = 11; advanced stage (AS) ( ), n = 8; and post
surgery at ES (PES) ( X ), n = 5; all non-obese. Columns repre-
sent means with s.d. APO A and B in PES patients were not
determined. 'Statistically significantly different from control value
(P<0.05).
Figure 2 shows that significant hyperglycaemia occurred in
ES and AS patients, but not in PES patients, while AS and
PES individuals also had decreased serum levels of trigly-
cerides (TG), LDL-cholesterol, Apo A, Apo B and CHOL.
Figure 2 also shows that ES patients had increased LDL and
CHOL values, reduced Apo A and normal levels of TG and
Apo B. HDL values were significantly elevated only in PES
patients.
The fatty acid concentration of LA in cancer patients was
significantly lower than in controls (20.5 ± 3.7 vs 26.4 ± 1.5).
This was compensated by an increase in palmitic acid
(21.6 ± 2.3 vs 17.7 ± 2.2). There were no significant
differences in storage fatty acids.
Discussion
The considerable hyperinsulinaemia seen in our tumour-
bearing patients may be caused by a combination of several
factors: (a) impaired insulin metabolism as seen in obesity;
(b) high consumption of LA (Lardinois et al., 1987); (c)
insulin secretion by insulin-producing/secreting tumours
(Yam, 1992); and (d) enhanced secretion of insulin by B cells
of the patient's pancreas induced by the tumour, presumably
via some messenger (Pavelic & Slijepcevic, 1978). Hyperin-
sulinaemia and insulin-like substances and insulin resistance
have been reported by Berstein et al. (1985) and Copeland et
al. (1987). Hyperinsulinaemia may evoke a down-regulation
of insulin receptors in normal but not cancerous cells
(Mountjoy et al., 1987), conferring on the latter serious
advantages in growth.
Of particular interest are the data on the SAT fatty acid
composition. These data show (a) that long-term LA intake
is very high in Israeli Jews, in agreement with earlier reports
(Berry et al., 1986) and (b) that our cancer patients had less
LA than the controls in SAT. The lower LA content of
cancer patients may reflect either a reduced long-term LA
intake or possibly an increased mobilisation of this fatty acid
for providing structural (e.g. arachidonic acid) and functional
elements (e.g. PGE2) involved in tumour development and
immunosuppression (Hubbard & Erikson, 1987; Karmali,
1987).
High consumption of LA has been reported to cause
hyperinsulinaemia and insulin resistance (Lardinois et al.,
1987) and may be the cause for the high prevalence of
glucose intolerance observed by Modan et al. (1985) in Israeli
Jews. Bitterman et al. (1991) reported a significantly greater
prevalence of urological cancer morbidity in Acre (Israel) as
compared with non-Jews. A similar trend of other cancers
was reported by the Israel Ministry of Health (1992). The
present results on blood lipids, especially the rise in CHOL
and LDL in ES patients, and the subsequent drop at AS, do
not permit conclusions regarding the role of blood choles-
terol in cancer. It is possible that, since cholesterol
metabolism is profoundly affected by insulin (Stolar, 1988),
abnormal blood cholesterol in tumour-bearing subjects may
be secondary to abnormal insulin regulation and metabolism
in malignancies.
Additional data may reinforce our interpretation and
avoid possible biases because of the small number of
cases.
The authors are indebted to P. Budowski for helpful discussions and
editorial assistance, and to M. Chen, M. Rozenberg and M. Lupo
for excellent laboratory assistance.
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